Discure Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Discure Technologies's estimated annual revenue is currently $2.9M per year.
- Discure Technologies's estimated revenue per employee is $221,538
Employee Data
- Discure Technologies has 13 Employees.
- Discure Technologies grew their employee count by 30% last year.
Discure Technologies's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Regulatory and Clinical Officer | Reveal Email/Phone |
3 | VP R&D | Reveal Email/Phone |
4 | Hardware Specialist | Reveal Email/Phone |
5 | R&D Electrical Engineer | Reveal Email/Phone |
Discure Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.9M | 13 | 30% | N/A | N/A |
#2 | $1.1M | 6 | 200% | N/A | N/A |
#3 | $9.2M | 30 | 3% | N/A | N/A |
#4 | $3.5M | 15 | 7% | $14M | N/A |
#5 | $4.5M | 17 | 0% | $53M | N/A |
#6 | $2.7M | 12 | -20% | N/A | N/A |
#7 | $2.7M | 12 | 20% | N/A | N/A |
#8 | $5.2M | 19 | 6% | $15M | N/A |
#9 | $7.9M | 26 | 8% | $9.7M | N/A |
What Is Discure Technologies?
The Discure System is designed to treat and reverse degenerative disc disease (DDD), healing the disc, reducing pain, and restoring function to patients, via a minimally invasive, implantable bioelectronic approach. \nUnlike existing treatments, that are symptom-focused, the Discure System is a disease-modifying solution, designed to reduce the use of opioids and the need for invasive back surgery. \nThe company received FDA Breakthrough Device Designation, was selected by FDA for the TAP program, and won multiple awards including for “Best New Technology in Spine Care” at the North American Spine Society (NASS) annual meeting, by a panel of KOL spinal surgeons and neurosurgeons.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2.9M
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.1M | 87 | 164% | $131M |